Anticoagulant Utilization and Cost Analysis among Cardiology Inpatients in a Tertiary Care Teaching Hospital of Western Nepal

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Characteristics</td><td class="align_center">Categories</td><td class="align_center"><i>n</i> (%)</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left" rowspan="2">Whether PT/INR/aPTT was performed or not? (<i>n</i> = 132)</td><td class="align_center">No</td><td class="align_center">16 (12.1)</td></tr><tr><td class="align_center">Yes</td><td class="align_center">116 (87.9)</td></tr><tr><td class="align_left" colspan="3"><hr/></td></tr><tr><td class="align_left" rowspan="2">RFT performance before enoxaparin (<i>n</i> = 117)</td><td class="align_center">No</td><td class="align_center">6 (5.13)</td></tr><tr><td class="align_center">Yes</td><td class="align_center">111 (94.87)</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div>PT: prothrombin time; INR: international normalized ratio; aPTT: activated partial thromboplastin time; RFT: renal function test.<br/></div></td></tr></table>

<div>PT/INR/aPTT test and renal function test performance before enoxaparin</div>

Advances in Pharmacological and Pharmaceutical Sciences

tab3

Table 3

Table 3: Anticoagulant Utilization and Cost Analysis among Cardiology Inpatients in a Tertiary Care Teaching Hospital of Western Nepal 